ENVVENO MEDICAL CORPORATION shareholders Q2 2024

ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 27 filers reported holding ENVVENO MEDICAL CORPORATION in Q2 2024. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

ENVVENO MEDICAL CORPORATION shareholders Q2 2024
NameSharesValueWeighting ↓
KINGDON CAPITAL MANAGEMENT, L.L.C. 653,870$3,432,8180.37%
ADAR1 Capital Management, LLC 201,728$1,059,0720.20%
Nantahala Capital Management 477,855$2,508,7390.15%
Perceptive Advisors 623,315$3,272,4040.08%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 230,790$1,211,6480.08%
Westside Investment Management, Inc. 38,762$203,5050.05%
Fermata Advisors, LLC 30,949$162,4820.04%
Laird Norton Wetherby Trust Company, LLC 33,000$173,2500.02%
ARTHUR M. COHEN & ASSOCIATES, LLC 14,000$73,5000.01%
GEODE CAPITAL MANAGEMENT, LLC 139,774$733,9350.00%
CIBC Private Wealth Group LLC 860$4,2830.00%
BlackRock Finance, Inc. 39,469$207,2130.00%
Citadel Advisors 37,400$196,3500.00%
Citadel Advisors 6,100$32,0250.00%
Citadel Advisors 7,145$37,5110.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 61,100$320,7750.00%
SIMPLEX TRADING, LLC 667$30.00%
Tower Research Capital LLC (TRC) 2,388$12,5370.00%
MORGAN STANLEY 94,873$498,0830.00%
STATE STREET CORP 26,500$139,1250.00%

This page lists ENVVENO MEDICAL CORPORATION's shareholders in Q2 2024. To view ENVVENO MEDICAL CORPORATION's shareholder history, click here.